A Discussion of COPD Surveillance Data

Published Online: Friday, January 17, 2014
Follow Pharmacy_Times:
In this podcast, Earl S. Ford, MD, MPH and David M. Mannino, MD, FCCP, discuss their study of surveillance results for COPD in the United States from 1999 to 2011 with CHEST podcast editor D. Kyle Hogarth, MD, FCCP.

To listen to this podcast, click here.
Related Articles
Clinical guidelines and government agencies are increasingly encouraging clinicians to consider patients’ treatment preferences when chronic disease is present.
Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about what the teach-back method is and the pharmacist's role in patient counseling.
The FDA today expanded the indication of fluticasone furoate/vilanterol (Breo Ellipta) for the treatment of asthma.
COPD patients must clear major hurdles before and after initiating nebulizer use.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$